SEC Form 4 · accession 0001179110-17-003682
ABBOTT LABORATORIES · ABT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Joseph J Manning
Officer — Senior Vice President
Period of report
Feb 28, 2017
Accepted (ET)
Mar 2, 2017 · 5:18 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000001800
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common shares without par valueF1 | Feb 28, 2017 | A | 5,085 | $45.46 | A | 25,231 | D | |
| Common shares without par value | Feb 28, 2017 | F | 1,463 | $45.46 | D | 23,768 | D | |
| Common shares without par value | Feb 28, 2017 | S | 387 | $44.9637 | D | 23,381 | D | |
| Common shares without par value | Feb 28, 2017 | S | 56 | $44.9636 | D | 23,325 | D | |
| Common shares without par value | Feb 28, 2017 | S | 300 | $44.9633 | D | 23,025 | D | |
| Common shares without par value | Feb 28, 2017 | S | 1 | $44.961 | D | 23,024 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Settlement of a performance-based restricted stock unit in shares in a transaction exempt from Section 16(b) under Rule 16b-3.
Remarks
The sale transaction was made pursuant to a previously adopted plan complying with Rule 10b5-1(c).